Paul Offit of the Perelman School of Medicine said it’s unlikely that a coronavirus vaccine will be ready by the end of the year given that Phase 3 trials have only just begun. Furthermore, he said, insufficient trials could damage not only public health but public trust in vaccines.

September 2, 2020 ・ From NPR